Hints and tips:
Related Special Reports
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...Pfizer spent $6.7bn on Arena Pharmaceuticals in December, lured by its medicines for immune-inflammatory diseases, and paid $2.3bn in August last year for Trillium Therapeutics as it targeted treatments...
...Antiviral medicines target viruses in a bid to prevent them infecting healthy cells, helping immune systems fight off the infection....
...Pfizer is close to acquiring Global Blood Therapeutics for about $5bn as the drugmaker taps the huge cash pile generated by the success of its Covid-19 vaccine to replenish its pipeline, according to people...
...It has also narrowed its focus on two therapeutic areas: oncology and neurology....
...A protein called tau, which forms brain “tangles”, is another therapeutic target. Inflammation is also a possible culprit....
...Jacob Glanville, a computational immunologist and founder of US therapeutics company Centivax, made the point that the 100-day timeframe was “crazy fast” and could not be shortened much more....
...Pfizer has agreed to buy oncology biotech Trillium Therapeutics in a deal worth about $2.3bn as the US drugmaker seeks to bolster its pipeline with a therapy it hopes will be transformative for blood cancers...
...It could be the first oral therapeutic, which patients would be able to take outside the hospital....
...The nanoparticle material is provided by companies such as Canada’s Acuitas Therapeutics and is then processed in preapproved facilities owned by Pfizer and BioNTech across the US and Europe....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...“Data sharing will greatly accelerate research into anti-Covid therapeutics and vaccines....
...Next will be three trials to treat cancer, including trying to edit immune cells to tackle solid tumours....
...Closure of processing facilities and reduction of fleet traffic can offset, but EBITDA will be well down on FY20. 1:30pm GMT - Silence Therapeutics is a company we flagged back on the legacy service in...
...Medical experts say that drinking can make it easier to catch Covid-19, and harder to recover because alcohol suppresses the immune system....
...AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal...
...Merck is also looking at other ways to bolster its oncology pipeline, including acquiring Peloton Therapeutics for up to $2.2bn last month....
...Movies have been uniquely immune from that.” Though it’s the most prominent, Netflix isn’t the only streaming platform grappling with the implications of the theatrical window in the internet age....
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...Dr Mukherjee said he believes this could spawn a “whole universe of drugs and therapeutic strategies”....
...“We found out the common denominator is that the immune system in the brain is not functioning....
...Till today, a systematic disease-modifying therapeutic approach remains empirical....
...Jounce Therapeutics, which had been touted as another star act, also looks set to disappoint....
...Immunotherapies work by allowing the body’s own immune system to attack tumour cells....
...According to Ben Shepherd, director of therapeutics at Organovo, the challenges ahead are about increasing the size of the tissue that can be grown....
International Edition